These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 23534612)

  • 1. Drugs, non-drugs, and disease category specificity: organ effects by ligand pharmacology.
    García-Sosa AT; Maran U
    SAR QSAR Environ Res; 2013; 24(4):319-31. PubMed ID: 23534612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DrugLogit: logistic discrimination between drugs and nondrugs including disease-specificity by assigning probabilities based on molecular properties.
    García-Sosa AT; Oja M; Hetényi C; Maran U
    J Chem Inf Model; 2012 Aug; 52(8):2165-80. PubMed ID: 22830445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure.
    Bender A; Scheiber J; Glick M; Davies JW; Azzaoui K; Hamon J; Urban L; Whitebread S; Jenkins JL
    ChemMedChem; 2007 Jun; 2(6):861-73. PubMed ID: 17477341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Strategy of molecular design of drugs: the unification of macro-properties and micro-structures of a molecule].
    Guo ZR
    Yao Xue Xue Bao; 2008 Mar; 43(3):227-33. PubMed ID: 18630256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Strategy of molecular drug design: activity and druggability].
    Guo ZR
    Yao Xue Xue Bao; 2010 May; 45(5):539-47. PubMed ID: 20931752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive activity profiling of drugs by topological-fragment-spectra-based support vector machines.
    Kawai K; Fujishima S; Takahashi Y
    J Chem Inf Model; 2008 Jun; 48(6):1152-60. PubMed ID: 18533712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Bayes affinity fingerprints" improve retrieval rates in virtual screening and define orthogonal bioactivity space: when are multitarget drugs a feasible concept?
    Bender A; Jenkins JL; Glick M; Deng Z; Nettles JH; Davies JW
    J Chem Inf Model; 2006; 46(6):2445-56. PubMed ID: 17125186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Global mapping of pharmacological space.
    Paolini GV; Shapland RH; van Hoorn WP; Mason JS; Hopkins AL
    Nat Biotechnol; 2006 Jul; 24(7):805-15. PubMed ID: 16841068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.
    Feher M; Schmidt JM
    J Chem Inf Comput Sci; 2003; 43(1):218-27. PubMed ID: 12546556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Are there differences between launched drugs, clinical candidates, and commercially available compounds?
    Ohno K; Nagahara Y; Tsunoyama K; Orita M
    J Chem Inf Model; 2010 May; 50(5):815-21. PubMed ID: 20394396
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling promiscuity based on in vitro safety pharmacology profiling data.
    Azzaoui K; Hamon J; Faller B; Whitebread S; Jacoby E; Bender A; Jenkins JL; Urban L
    ChemMedChem; 2007 Jun; 2(6):874-80. PubMed ID: 17492703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging chemical patterns: a new methodology for molecular classification and compound selection.
    Auer J; Bajorath J
    J Chem Inf Model; 2006; 46(6):2502-14. PubMed ID: 17125191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using novel descriptor accounting for ligand-receptor interactions to define and visually explore biologically relevant chemical space.
    Rabal O; Oyarzabal J
    J Chem Inf Model; 2012 May; 52(5):1086-102. PubMed ID: 22486368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compendium of drugs commonly used in cell biology research.
    Cole NH
    Curr Protoc Cell Biol; 2001 May; Appendix 1():Appendix 1B. PubMed ID: 18228274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organic chemistry in drug discovery.
    MacCoss M; Baillie TA
    Science; 2004 Mar; 303(5665):1810-3. PubMed ID: 15031494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Principles of pharmacodynamics and their applications in veterinary pharmacology.
    Lees P; Cunningham FM; Elliott J
    J Vet Pharmacol Ther; 2004 Dec; 27(6):397-414. PubMed ID: 15601436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Considering the impact drug-like properties have on the chance of success.
    Yusof I; Segall MD
    Drug Discov Today; 2013 Jul; 18(13-14):659-66. PubMed ID: 23458995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selection criteria for drug-like compounds.
    Muegge I
    Med Res Rev; 2003 May; 23(3):302-21. PubMed ID: 12647312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-related differences in the physical property profiles of oral drugs.
    Leeson PD; Davis AM
    J Med Chem; 2004 Dec; 47(25):6338-48. PubMed ID: 15566303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.